Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 1
2011 1
2012 3
2013 4
2014 1
2015 2
2016 1
2017 1
2018 4
2019 5
2020 4
2021 4
2022 7
2023 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
Piselli P, Tavelli A, Cimaglia C, Muccini C, Bandera A, Marchetti GC, Torti C, Mazzotta V, Pipitò L, Caioli A, Girardi E, Antinori A, Serraino D, d'Arminio Monforte A, Cingolani A; Icona Foundation Study Group. Piselli P, et al. Among authors: cimaglia c. Int J Cancer. 2025 Sep 15;157(6):1142-1153. doi: 10.1002/ijc.35493. Epub 2025 May 29. Int J Cancer. 2025. PMID: 40437996 Free PMC article.
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy.
Taborelli M, Serraino D, Cimaglia C, Furian L, Biancone L, Busnach G, Bossini N, Citterio F, Veroux M, Iaria M, Argiolas D, Todeschini P, Manzia TM, Pisani F, Cantaluppi V, Simone S, Mangino M, Campise M, Ambrosini A, Caputo F, Piselli P; Italian Transplant and Cancer Cohort Study. Taborelli M, et al. Among authors: cimaglia c. Int J Cancer. 2024 Mar 1;154(5):842-851. doi: 10.1002/ijc.34787. Epub 2023 Nov 4. Int J Cancer. 2024. PMID: 37924271
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials.
Mazzotta V, Lepri AC, Del Borgo C, Lanini S, Meschi S, Garattini S, Rosati S, Siciliano V, Vergori A, Coppola L, Falletta A, Carraro A, Gramigna G, Oliva A, Matteini E, Gasperin A, Giannico G, Mastrorosa I, Matusali G, D'Abramo A, Marocco R, Milozzi E, Cerva C, Gavaruzzi F, Rueca M, Cimaglia C, Piselli P, Fantoni M, Girardi E, Sarmati L, Mastroianni CM, Andreoni M, Torti C, Nicastri E, Maggi F, Lichtner M, Antinori A; Early Treatment for COVID‐19 Lazio Study Group. Mazzotta V, et al. Among authors: cimaglia c. J Med Virol. 2025 May;97(5):e70379. doi: 10.1002/jmv.70379. J Med Virol. 2025. PMID: 40326978 Free PMC article.
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route.
Mazzotta V, Piselli P, Cozzi Lepri A, Matusali G, Cimini E, Esvan R, Colavita F, Gagliardini R, Notari S, Oliva A, Meschi S, Casetti R, Micheli G, Bordi L, Giacinta A, Grassi G, Gebremeskel Tekle S, Cimaglia C, Paulicelli J, Caioli A, Gallì P, Del Duca G, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Latini A, Faccendini P, Fontana C, Nicastri E, Siddu A, Barca A, Vaia F, Girardi E, Maggi F, Antinori A; MPOX Vaccine Lazio Study Group. Mazzotta V, et al. Among authors: cimaglia c. Vaccines (Basel). 2024 Dec 31;13(1):32. doi: 10.3390/vaccines13010032. Vaccines (Basel). 2024. PMID: 39852811 Free PMC article.
Four months daily rifampicin vs. 3 months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trial.
Matteelli A, Russo G, Rossi L, Cerini C, Cimaglia C, Formenti B, Dall'Asta M, Cristini I, Gregori N, Ghilardi C, Ciccarone A, Previtali L, Di Rosario G, Cirillo DM, Girardi E. Matteelli A, et al. Among authors: cimaglia c. Clin Microbiol Infect. 2025 Aug;31(8):1330-1335. doi: 10.1016/j.cmi.2025.02.037. Epub 2025 Mar 1. Clin Microbiol Infect. 2025. PMID: 40032083 Clinical Trial.
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
Mazzotta V, Lepri AC, Matusali G, Cimini E, Piselli P, Aguglia C, Lanini S, Colavita F, Notari S, Oliva A, Meschi S, Casetti R, Mondillo V, Vergori A, Bettini A, Grassi G, Pinnetti C, Lapa D, Tartaglia E, Gallì P, Mondi A, Montagnari G, Gagliardini R, Nicastri E, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Stingone C, Siddu A, Barca A, Fontana C, Agrati C, Girardi E, Vaia F, Maggi F, Antinori A; Mpox Vaccine Lazio Study Group. Mazzotta V, et al. EClinicalMedicine. 2024 Jan 12;68:102420. doi: 10.1016/j.eclinm.2023.102420. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38292040 Free PMC article.
50 results